# Advanced Energy Industries Inc: financial statements, quarterly

AEIS · Nasdaq · CIK 927003 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aeis.md) · [Financials](/companies/aeis/financials.md) · [Filings](/companies/aeis/filings.md) · [Insiders](/companies/aeis/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aeis/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [410](/filings/0001558370-24-013949.md) | [405 d](/filings/0001104659-26-014731.md) | [328](/filings/0001558370-25-005998.md) | [365](/filings/0001558370-25-010287.md) | [374](/filings/0000927003-25-000023.md) | [415 d](/filings/0001104659-26-014731.md) | [405](/filings/0000927003-26-000014.md) | [442](/filings/0000927003-26-000032.md) | [463](/filings/0000927003-25-000023.md) | [489 d](/filings/0001104659-26-014731.md) | [511](/filings/0000927003-26-000014.md) | [574](/filings/0000927003-26-000032.md) |
| Cost of revenue | $m | [263](/filings/0001558370-24-013949.md) | [262 d](/filings/0001104659-26-014731.md) | [215](/filings/0001558370-25-005998.md) | [237](/filings/0001558370-25-010287.md) | [240](/filings/0000927003-25-000023.md) | [261 d](/filings/0001104659-26-014731.md) | [254](/filings/0000927003-26-000014.md) | [278](/filings/0000927003-26-000032.md) | [289](/filings/0000927003-25-000023.md) | [300 d](/filings/0001104659-26-014731.md) | [310](/filings/0000927003-26-000014.md) | [338](/filings/0000927003-26-000032.md) |
| Gross profit | $m | [147](/filings/0001558370-24-013949.md) | [143 d](/filings/0001104659-26-014731.md) | [113](/filings/0001558370-25-005998.md) | [128](/filings/0001558370-25-010287.md) | [134](/filings/0000927003-25-000023.md) | [155 d](/filings/0001104659-26-014731.md) | [151](/filings/0000927003-26-000014.md) | [163](/filings/0000927003-26-000032.md) | [174](/filings/0000927003-25-000023.md) | [189 d](/filings/0001104659-26-014731.md) | [201](/filings/0000927003-26-000014.md) | [236](/filings/0000927003-26-000032.md) |
| Research and development | $m | [50.4](/filings/0001558370-24-013949.md) | [49.0 d](/filings/0001104659-26-014731.md) | [49.8](/filings/0001558370-25-005998.md) | [52.3](/filings/0001558370-25-010287.md) | [53.6](/filings/0000927003-25-000023.md) | [56.1 d](/filings/0001104659-26-014731.md) | [54.2](/filings/0000927003-26-000014.md) | [59.0](/filings/0000927003-26-000032.md) | [59.1](/filings/0000927003-25-000023.md) | [60.1 d](/filings/0001104659-26-014731.md) | [62.4](/filings/0000927003-26-000014.md) | [65.0](/filings/0000927003-26-000032.md) |
| Selling, general and administrative | $m | [55.1](/filings/0001558370-24-013949.md) | [54.9 d](/filings/0001104659-26-014731.md) | [55.1](/filings/0001558370-25-005998.md) | [55.1](/filings/0001558370-25-010287.md) | [56.2](/filings/0000927003-25-000023.md) | [58.2 d](/filings/0001104659-26-014731.md) | [59.0](/filings/0000927003-26-000014.md) | [60.2](/filings/0000927003-26-000032.md) | [59.8](/filings/0000927003-25-000023.md) | [63.4 d](/filings/0001104659-26-014731.md) | [62.3](/filings/0000927003-26-000014.md) | [69.4](/filings/0000927003-26-000032.md) |
| Operating income | $m | [30.1](/filings/0001558370-24-013949.md) | [13.8 d](/filings/0001104659-26-014731.md) | [0.9](/filings/0001558370-25-005998.md) | [12.9](/filings/0001558370-25-010287.md) | [(11.0)](/filings/0000927003-25-000023.md) | [33.8 d](/filings/0001104659-26-014731.md) | [30.6](/filings/0000927003-26-000014.md) | [31.6](/filings/0000927003-26-000032.md) | [49.2](/filings/0000927003-25-000023.md) | [56.6 d](/filings/0001104659-26-014731.md) | [68.3](/filings/0000927003-26-000014.md) | [95.1](/filings/0000927003-26-000032.md) |
| Interest expense | $m | [3.8](/filings/0001558370-24-013949.md) | [7.2 d](/filings/0001104659-26-014731.md) | [7.1](/filings/0001558370-25-005998.md) | [7.0](/filings/0001558370-25-010287.md) | [6.4](/filings/0000927003-25-000023.md) | [4.6 d](/filings/0001104659-26-014731.md) | [4.2](/filings/0000927003-26-000014.md) | [4.2](/filings/0000927003-26-000032.md) | [4.2](/filings/0000927003-25-000023.md) | [4.1 d](/filings/0001104659-26-014731.md) | [4.1](/filings/0000927003-26-000014.md) | [3.3](/filings/0000927003-26-000032.md) |
| Income tax | $m | [0.9](/filings/0001558370-24-013949.md) | [(21.7) d](/filings/0001104659-26-014731.md) | [1.8](/filings/0001558370-25-005998.md) | [3.2](/filings/0001558370-25-010287.md) | [(0.4)](/filings/0000927003-25-000023.md) | [(8.5) d](/filings/0001104659-26-014731.md) | [5.0](/filings/0000927003-26-000014.md) | [3.8](/filings/0000927003-26-000032.md) | [5.9](/filings/0000927003-25-000023.md) | [4.7 d](/filings/0001104659-26-014731.md) | [2.7](/filings/0000927003-26-000014.md) | [12.1](/filings/0000927003-26-000032.md) |
| Net income | $m | [32.7](/filings/0001558370-24-013949.md) | [37.5 d](/filings/0001558370-25-001038.md) | [5.4](/filings/0001558370-25-005998.md) | [14.8](/filings/0001558370-25-010287.md) | [(14.9)](/filings/0001558370-24-013949.md) | [48.9 d](/filings/0001558370-25-001038.md) | [24.7](/filings/0001558370-25-005998.md) | [25.2](/filings/0001558370-25-010287.md) | [46.2](/filings/0000927003-25-000023.md) | [52.3 d](/filings/0001104659-26-014731.md) | [66.8](/filings/0000927003-26-000032.md) | [54.1](/filings/0000927003-26-000032.md) |
| Diluted EPS | $ per share | [0.86](/filings/0001558370-24-013949.md) | not reported | [0.14](/filings/0001558370-25-005998.md) | [0.39](/filings/0001558370-25-010287.md) | [(0.40)](/filings/0000927003-25-000023.md) | not reported | [0.65](/filings/0000927003-26-000014.md) | [0.67](/filings/0000927003-26-000032.md) | [1.20](/filings/0000927003-25-000023.md) | not reported | [1.58](/filings/0000927003-26-000014.md) | [1.28](/filings/0000927003-26-000032.md) |
| Basic EPS | $ per share | [0.87](/filings/0001558370-24-013949.md) | not reported | [0.14](/filings/0001558370-25-005998.md) | [0.39](/filings/0001558370-25-010287.md) | [(0.40)](/filings/0000927003-25-000023.md) | not reported | [0.66](/filings/0000927003-26-000014.md) | [0.67](/filings/0000927003-26-000032.md) | [1.23](/filings/0000927003-25-000023.md) | not reported | [1.77](/filings/0000927003-26-000014.md) | [1.39](/filings/0000927003-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [986](/filings/0001558370-23-017112.md) | [1,045](/filings/0001558370-25-001038.md) | [1,018](/filings/0001558370-24-006384.md) | [986](/filings/0001558370-24-010375.md) | [657](/filings/0001558370-24-013949.md) | [722](/filings/0001104659-26-014731.md) | [723](/filings/0001558370-25-005998.md) | [714](/filings/0001558370-25-010287.md) | [759](/filings/0000927003-25-000023.md) | [791](/filings/0000927003-26-000032.md) | [700](/filings/0000927003-26-000014.md) | [1,397](/filings/0000927003-26-000032.md) |
| Current assets | $m | [1,673](/filings/0001558370-23-017112.md) | [1,712](/filings/0001558370-25-001038.md) | [1,672](/filings/0001558370-24-006384.md) | [1,678](/filings/0001558370-24-010375.md) | [1,346](/filings/0001558370-24-013949.md) | [1,389](/filings/0001104659-26-014731.md) | [1,414](/filings/0001558370-25-005998.md) | [1,460](/filings/0001558370-25-010287.md) | [1,503](/filings/0000927003-25-000023.md) | [1,574](/filings/0000927003-26-000032.md) | [1,589](/filings/0000927003-26-000014.md) | [2,411](/filings/0000927003-26-000032.md) |
| Total assets | $m | [2,494](/filings/0001558370-23-017112.md) | [2,557](/filings/0001558370-25-001038.md) | [2,524](/filings/0001558370-24-006384.md) | [2,542](/filings/0001558370-24-010375.md) | [2,193](/filings/0001558370-24-013949.md) | [2,262](/filings/0001104659-26-014731.md) | [2,302](/filings/0001558370-25-005998.md) | [2,380](/filings/0001558370-25-010287.md) | [2,438](/filings/0000927003-25-000023.md) | [2,546](/filings/0000927003-26-000032.md) | [2,593](/filings/0000927003-26-000014.md) | [3,427](/filings/0000927003-26-000032.md) |
| Current liabilities | $m | [315](/filings/0001558370-23-017112.md) | [336](/filings/0001558370-25-001038.md) | [298](/filings/0001558370-24-006384.md) | [307](/filings/0001558370-24-010375.md) | [292](/filings/0001558370-24-013949.md) | [314](/filings/0001104659-26-014731.md) | [319](/filings/0001558370-25-005998.md) | [357](/filings/0001558370-25-010287.md) | [367](/filings/0000927003-25-000023.md) | [991](/filings/0000927003-26-000032.md) | [1,001](/filings/0000927003-26-000014.md) | [636](/filings/0000927003-26-000032.md) |
| Total liabilities | $m | [1,393](/filings/0001558370-23-017112.md) | [1,413](/filings/0001558370-25-001038.md) | [1,381](/filings/0001558370-24-006384.md) | [1,377](/filings/0001558370-24-010375.md) | [1,028](/filings/0001558370-24-013949.md) | [1,055](/filings/0001104659-26-014731.md) | [1,068](/filings/0001558370-25-005998.md) | [1,117](/filings/0001558370-25-010287.md) | [1,124](/filings/0000927003-25-000023.md) | [1,175](/filings/0000927003-26-000032.md) | [1,190](/filings/0000927003-26-000014.md) | [1,950](/filings/0000927003-26-000032.md) |
| Long-term debt | $m | [900](/filings/0001558370-23-017112.md) | [896](/filings/0001558370-25-001038.md) | [891](/filings/0001558370-24-006384.md) | [887](/filings/0001558370-24-010375.md) | [564](/filings/0001558370-24-013949.md) | [565](/filings/0001104659-26-014731.md) | [565](/filings/0001558370-25-005998.md) | [566](/filings/0001558370-25-010287.md) | [567](/filings/0000927003-25-000023.md) | [568](/filings/0000927003-26-000032.md) | [568](/filings/0000927003-26-000014.md) | [1,129](/filings/0000927003-26-000032.md) |
| Current portion of debt | $m | [20.0](/filings/0001558370-23-017112.md) | [20.0](/filings/0001558370-25-001038.md) | [20.0](/filings/0001558370-24-006384.md) | [20.0](/filings/0001558370-24-010375.md) | not reported | not reported | not reported | not reported | not reported | [568](/filings/0000927003-26-000032.md) | [568](/filings/0000927003-26-000014.md) | [136](/filings/0000927003-26-000032.md) |
| Shareholders' equity | $m | [1,101](/filings/0001558370-24-013949.md) | [1,144](/filings/0001104659-26-014731.md) | [1,143](/filings/0000927003-25-000023.md) | [1,165](/filings/0000927003-25-000023.md) | [1,164](/filings/0000927003-25-000023.md) | [1,203](/filings/0000927003-26-000032.md) | [1,230](/filings/0000927003-26-000032.md) | [1,257](/filings/0000927003-26-000032.md) | [1,307](/filings/0000927003-25-000023.md) | [1,363](/filings/0000927003-26-000032.md) | [1,384](/filings/0000927003-26-000032.md) | [1,456](/filings/0000927003-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [72.5 d](/filings/0001558370-24-013949.md) | [84.0 d](/filings/0001104659-26-014731.md) | [7.3](/filings/0001558370-25-005998.md) | [6.7 d](/filings/0001558370-25-010287.md) | [34.2 d](/filings/0000927003-25-000023.md) | [82.6 d](/filings/0001104659-26-014731.md) | [28.9](/filings/0000927003-26-000014.md) | [45.2 d](/filings/0000927003-26-000032.md) | [78.7 d](/filings/0000927003-25-000023.md) | [80.5 d](/filings/0001104659-26-014731.md) | [(6.0)](/filings/0000927003-26-000014.md) | [85.0 d](/filings/0000927003-26-000032.md) |
| Capital expenditure | $m | [13.2 d](/filings/0001558370-24-013949.md) | [14.2 d](/filings/0001104659-26-014731.md) | [16.6](/filings/0001558370-25-005998.md) | [14.8 d](/filings/0001558370-25-010287.md) | [12.6 d](/filings/0000927003-25-000023.md) | [12.8 d](/filings/0001104659-26-014731.md) | [13.9](/filings/0000927003-26-000014.md) | [28.1 d](/filings/0000927003-26-000032.md) | [27.9 d](/filings/0000927003-25-000023.md) | [37.5 d](/filings/0001104659-26-014731.md) | [36.6](/filings/0000927003-26-000014.md) | [49.5 d](/filings/0000927003-26-000032.md) |
| Dividends paid | $m | [3.8 d](/filings/0001558370-24-013949.md) | [3.8 d](/filings/0001104659-26-014731.md) | [3.8](/filings/0001558370-25-005998.md) | [3.9 d](/filings/0001558370-25-010287.md) | [3.9 d](/filings/0000927003-25-000023.md) | [3.8 d](/filings/0001104659-26-014731.md) | [3.8](/filings/0000927003-26-000014.md) | [3.9 d](/filings/0000927003-26-000032.md) | [3.9 d](/filings/0000927003-25-000023.md) | [4.0 d](/filings/0001104659-26-014731.md) | [3.8](/filings/0000927003-26-000014.md) | [4.1 d](/filings/0000927003-26-000032.md) |
| Share repurchases | $m | [40.0](/filings/0001558370-24-013949.md) | [0.0 d](/filings/0001104659-26-014731.md) | not reported | not reported | [1.8](/filings/0001558370-24-013949.md) | [0.0 d](/filings/0001104659-26-014731.md) | [0.5](/filings/0000927003-26-000014.md) | [23.2 d](/filings/0000927003-26-000032.md) | [0.0 d](/filings/0000927003-25-000023.md) | [6.5 d](/filings/0001104659-26-014731.md) | [0.5](/filings/0000927003-26-000014.md) | [0.0 d](/filings/0000927003-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.6](/filings/0001558370-23-017112.md) | [37.8](/filings/0001558370-24-006384.md) | [37.8](/filings/0001558370-24-010375.md) | [37.9](/filings/0001558370-24-013949.md) | [37.7](/filings/0001558370-25-005998.md) | [37.8](/filings/0001558370-25-010287.md) | [37.5](/filings/0000927003-25-000023.md) | [38.1](/filings/0000927003-26-000014.md) | [37.8](/filings/0000927003-26-000032.md) | [38.5](/filings/0000927003-25-000023.md) | [42.2](/filings/0000927003-26-000014.md) | [42.3](/filings/0000927003-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,050,442 at 2026-07-29, from the cover of the [10-Q filed 2026-08-03](/filings/0000927003-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.